News Image

Amneal Reports Third Quarter 2025 Financial Results

Provided By GlobeNewswire

Last update: Oct 30, 2025

Q3 2025 Net Revenue of $785 million; GAAP Net Income of $2 million; Diluted Income per Share of $0.01
‒ Adjusted EBITDA of $160 million; Adjusted Diluted EPS of $0.17
‒ Updated 2025 Full Year Guidance ‒

Read more at globenewswire.com

AMNEAL PHARMACEUTICALS INC

NASDAQ:AMRX (12/15/2025, 10:05:46 AM)

12.345

+0.13 (+1.11%)



Find more stocks in the Stock Screener

Follow ChartMill for more